Status:
UNKNOWN
Simultaneous Study of the Serum Tryptase Level of the Mother and the Child During Childbirth (TryPla)
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Newborn
Parturient
Eligibility:
All Genders
Phase:
NA
Brief Summary
Currently the neonatal serum level of severals proteins can be used as an indicator of subsequent risk. For example, we plan to explore the neonatal kinetics of tryptase and other immune proteins as p...
Detailed Description
* The protocole will be explain to the family in delivery room, an information note will be given, and we will let the time to think about it. * In a second time investigator will make the mother sign...
Eligibility Criteria
Inclusion
- Mother-child couple
- Childbirth at the Clermont-Ferrand University Hospital.
- Affiliated to a social security system
Exclusion
- Newborns whose holders of parental authority are protected by law (under guardianship, placed under the protection of justice)
- Newborns whose holders of parental authority are under the age of 18
- Fetal pathology, excluding prematurity.
- emergency caesarean section, because o life threatening condition for the fetus or the mother.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04441463
Start Date
September 1 2020
End Date
December 1 2020
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000